Partial Epilepsy Clinical Trial
Official title:
Thermographic Examination of Low Back and Abdominal Area Skin Temperatures in Individuals With and Without Focal Onset Epilepsy
Verified date | June 2011 |
Source | Atlantic University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The specific aim is to determine if there are patterns of temperature differences in the abdominal and back regions of individuals with partial/focal onset epilepsy as compared to a non-epileptic control group. The hypothesis is that individuals with partial/focal onset epilepsy will have colder recorded temperatures in the abdominal area than individuals in a matched control group.
Status | Completed |
Enrollment | 100 |
Est. completion date | April 2012 |
Est. primary completion date | April 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria Experimental Group: 1. Diagnosis of Partial/Focal Onset Epilepsy (ICD9-CM 345.4 and 345.5) 2. Ages 18-70 Exclusion Criteria Experimental Group: 1. Pregnancy 2. Recent trauma such as motor vehicle accident or injury to the musculoskeletal system 3. Currently on medication, other than for epilepsy which may affect autonomic nervous system function, e.g. Glaucoma medication 4. If diagnosed with a condition which could affect abdominal area neurophysiologic functions. 1. Irritable bowel syndrome 2. Crohn's disease 3. Ulcerative colitis 4. Migraine headache with abdominal manifestation Inclusion criteria Control group: 1. No history or diagnosis of any seizure disorder 2. Ages 18-70 Exclusion Criteria Control group: 1. Pregnancy 2. Recent trauma such as motor vehicle accident or injury to the musculoskeletal system 3. Currently on medication, other than for epilepsy which may affect autonomic nervous system function, e.g. Glaucoma medication 4. If diagnosed with a condition which could affect abdominal area neurophysiologic functions. 1. Irritable bowel syndrome 2. Crohn's disease 3. Ulcerative colitis 4. Migraine headache with abdominal manifestation |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Epilepsy Foundation of Florida | Miami | Florida |
Lead Sponsor | Collaborator |
---|---|
Atlantic University | A.T. Still University of Health Sciences |
United States,
Henkel A, Noachtar S, Pfänder M, Lüders HO. The localizing value of the abdominal aura and its evolution: a study in focal epilepsies. Neurology. 2002 Jan 22;58(2):271-6. — View Citation
Zinkin NT, Peppercorn MA. Abdominal epilepsy. Best Pract Res Clin Gastroenterol. 2005 Apr;19(2):263-74. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Thermographic imagery of the abdominal area | State of the art thermographic imagery of the imagery of the abdominal area from the xyphoid bone to just above the public symphysis. It is hypothesized that the average temperature for the experimental group will be lower than the control group. Since this is a measurement or diagnostic study using thermographic imagery, there is no health risk to the subjects. | Each experimental subject and each control subject will be seen once for the administration of the thermography imagery | No |
Secondary | low back thermography imagery | Besides abdominal area will also do theographic imagery of low back of subjects because of the possibility of dermatomal skin area temperature changes possibly related the "Abdominal Epilepsy" dysfunction of the Celiac, Superior Mesenteric and Inferior Mesenteric Ganglia | one time for thermographic imagery | No |
Secondary | side thermography imagery | To capture possible dermatomal skin temperature effects will do thermographic imagery of the side or lateral aspect of the subjects. | one time for thermographic imagery | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00982787 -
Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy
|
Phase 2 | |
Completed |
NCT00898560 -
Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive
|
Phase 1 | |
Recruiting |
NCT01735032 -
Multimodal Imaging in Pre-surgical Evaluation of Epilepsy
|
N/A | |
Completed |
NCT01090934 -
Localizing the Epileptogenic Zone With High Resolution Electroencephalography
|
N/A | |
Terminated |
NCT00391534 -
EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
|
Phase 3 | |
Terminated |
NCT01496612 -
Buspirone Therapy for Localized Epilepsy
|
Phase 2 | |
Completed |
NCT00900237 -
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
|
Phase 1 | |
Recruiting |
NCT04903314 -
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
|
Phase 1 | |
Completed |
NCT00894478 -
Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor Imaging
|
N/A | |
Recruiting |
NCT03478852 -
Investigating Epilepsy: Screening and Evaluation
|
||
Recruiting |
NCT01273129 -
Surgery as a Treatment for Medically Intractable Epilepsy
|
||
Completed |
NCT00001666 -
Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy
|
N/A | |
Completed |
NCT00001932 -
Serotonin Receptors in Seizure Disorders
|
N/A | |
Completed |
NCT00908349 -
Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy
|
Phase 3 | |
Completed |
NCT02076698 -
Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy
|
Phase 3 | |
Completed |
NCT00706160 -
Language Mapping in Patients With Epilepsy
|
||
Completed |
NCT01397968 -
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
|
Phase 2 | |
Completed |
NCT01866111 -
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
|
Phase 2 | |
Completed |
NCT00957047 -
Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy
|
Phase 3 | |
Terminated |
NCT01281956 -
PRX-00023 Therapy in Localization-Related Epilepsy
|
Phase 2 |